scholarly article | Q13442814 |
P50 | author | Emily Chew | Q24266614 |
Catherine Cukras | Q83234056 | ||
Elvira Agrón | Q83234331 | ||
Traci E Clemons | Q92993074 | ||
Frederick Ferris | Q96025318 | ||
Shaza N Al-Holou | Q96164290 | ||
Age-Related Eye Disease Study 2 Research Group | Q117242065 | ||
P2093 | author name string | William R Tucker | |
P2860 | cites work | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 |
Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3 | Q24545563 | ||
Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial. | Q37456394 | ||
Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008. | Q37697907 | ||
Dietary fat and fish intake and age-related maculopathy | Q39531709 | ||
HMG-CoA reductase inhibitors for treatment of hypercholesterolemia | Q39645793 | ||
Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement | Q39699065 | ||
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies | Q41962966 | ||
Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey | Q43853947 | ||
Recent statin use and 1-year incidence of exudative age-related macular degeneration | Q46292683 | ||
Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study. | Q50470529 | ||
Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. | Q50489615 | ||
Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. | Q51515497 | ||
Relation of Statin Use to the 5-Year Incidence and Progression of Age-Related Maculopathy | Q57232781 | ||
C-reactive protein level and risk of aging macula disorder: The Rotterdam Study | Q81411125 | ||
The use of cholesterol-lowering medications and age-related macular degeneration | Q81474220 | ||
3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study | Q82214567 | ||
Persistence with statins and incident cataract: a population-based historical cohort study | Q82738915 | ||
Statins do not decrease the risk for wet age-related macular degeneration | Q83672963 | ||
Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration | Q28168074 | ||
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration | Q28190470 | ||
Seven new loci associated with age-related macular degeneration | Q29416998 | ||
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) | Q29547825 | ||
Prevalence of age-related macular degeneration in the United States | Q29614964 | ||
Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management. | Q30308718 | ||
Accumulation of cholesterol with age in human Bruch's membrane. | Q31776587 | ||
Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials | Q34065021 | ||
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors | Q34207135 | ||
Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration | Q34395891 | ||
Statins and the risk of dementia | Q34511970 | ||
Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration | Q34548871 | ||
High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women | Q34565911 | ||
Pleiotropic effects of HMG-CoA reductase inhibitors | Q34632185 | ||
Statin induced myopathy | Q34874022 | ||
Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins | Q35056603 | ||
Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies | Q35126780 | ||
The association between statin use and age related maculopathy | Q35591461 | ||
A case control study of age related macular degeneration and use of statins. | Q35593614 | ||
The epidemiology of age-related macular degeneration | Q35688105 | ||
Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy | Q35749021 | ||
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) | Q36360812 | ||
C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts | Q36763239 | ||
Risk of macular degeneration in users of statins: cross sectional study. | Q37085714 | ||
P433 | issue | 12 | |
P921 | main subject | eye disease | Q3041498 |
macular degeneration | Q27429789 | ||
P304 | page(s) | 2490-2496 | |
P577 | publication date | 2015-10-01 | |
P1433 | published in | Ophthalmology | Q7098109 |
P1476 | title | The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9 | |
P478 | volume | 122 |
Q89267042 | Disrupted cholesterol metabolism promotes age-related photoreceptor neurodegeneration |
Q30239897 | Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors |
Q91655266 | Statins as anti-inflammatory agents: A potential therapeutic role in sight-threatening non-infectious uveitis |
Q59813666 | The Question of a Role for Statins in Age-Related Macular Degeneration |
Search more.